Proteomes of Paired Human Cerebrospinal Fluid and Plasma: Relation to Blood-Brain Barrier Permeability in Older Adults.

The systems-level relationship between the proteomes of cerebrospinal fluid (CSF) and plasma has not been comprehensively described so far. Recently developed shotgun proteomic workflows allow for deeper characterization of the proteomes from body fluids in much larger sample size. We deployed state-of-the-art mass spectrometry-based proteomics in paired CSF and plasma samples volunteered by 120 elders with and without cognitive impairment to comprehensively characterize and examine compartmental proteome differences and relationships between both body fluids. We further assessed the influence of blood-brain barrier (BBB) integrity and tested the hypothesis that BBB breakdown can be identified from CSF and plasma proteome alterations in nondemented elders. We quantified 790 proteins in CSF and 422 proteins in plasma, and 255 of the proteins were identified in both compartments. Pearson's statistics determined 28 proteins with associated levels between CSF and plasma. BBB integrity as defined with the CSF/serum albumin index influenced 76 CSF/plasma protein ratios. In least absolute shrinkage and selection operator models, CSF and plasma proteins improved identification of BBB impairment. In conclusion, we provide here a first comprehensive draft map of interacting human CSF and plasma proteomes, in view of their complex and dynamic compositions, and influence of the BBB.

[1]  S. Gygi,et al.  Proteomic Profiling of Extracellular Vesicles Isolated From Cerebrospinal Fluid of Former National Football League Players at Risk for Chronic Traumatic Encephalopathy , 2019, Front. Neurosci..

[2]  Loïc Dayon,et al.  Deep Dive on the Proteome of Human Cerebrospinal Fluid: A Valuable Data Resource for Biomarker Discovery and Missing Protein Identification. , 2018, Journal of proteome research.

[3]  J. Wojcik,et al.  Blood-brain barrier breakdown, neuroinflammation, and cognitive decline in older adults , 2018, Alzheimer's & Dementia.

[4]  L. Dayon,et al.  Identification of Missing Proteins in Normal Human Cerebrospinal Fluid. , 2018, Journal of proteome research.

[5]  K. Blennow,et al.  Evidence for sex difference in the CSF/plasma albumin ratio in ~20 000 patients and 335 healthy volunteers , 2018, Journal of cellular and molecular medicine.

[6]  J. Wojcik,et al.  Alzheimer disease pathology and the cerebrospinal fluid proteome , 2018, Alzheimer's Research & Therapy.

[7]  Christopher Fowler,et al.  Systematic Evaluation of the Use of Human Plasma and Serum for Mass-Spectrometry-Based Shotgun Proteomics. , 2018, Journal of proteome research.

[8]  A. Astrup,et al.  The differential plasma proteome of obese and overweight individuals undergoing a nutritional weight loss and maintenance intervention , 2018, Proteomics. Clinical applications.

[9]  S. Misra,et al.  Blood‐based protein biomarkers for stroke differentiation: A systematic review , 2017, Proteomics. Clinical applications.

[10]  Matthias Mann,et al.  Revisiting biomarker discovery by plasma proteomics , 2017, Molecular systems biology.

[11]  J. Wojcik,et al.  Markers of neuroinflammation associated with Alzheimer’s disease pathology in older adults , 2017, Brain, Behavior, and Immunity.

[12]  M. Laakso,et al.  The influence of insulin resistance on cerebrospinal fluid and plasma biomarkers of Alzheimer’s pathology , 2017, Alzheimer's Research & Therapy.

[13]  D. Galasko,et al.  Alzheimer disease: CSF biomarkers for Alzheimer disease — approaching consensus , 2017, Nature Reviews Neurology.

[14]  P. Snyder,et al.  Blood-based biomarkers in Alzheimer disease: Current state of the science and a novel collaborative paradigm for advancing from discovery to clinic , 2017, Alzheimer's & Dementia.

[15]  Matthias Mann,et al.  Proteomics reveals the effects of sustained weight loss on the human plasma proteome , 2016, Molecular systems biology.

[16]  Minoru Kanehisa,et al.  KEGG: new perspectives on genomes, pathways, diseases and drugs , 2016, Nucleic Acids Res..

[17]  Cathy H. Wu,et al.  UniProt: the universal protein knowledgebase , 2016, Nucleic Acids Research.

[18]  Juan Antonio Vizcaíno,et al.  The ProteomeXchange consortium in 2017: supporting the cultural change in proteomics public data deposition , 2016, Nucleic Acids Res..

[19]  Ruedi Aebersold,et al.  Mass-spectrometric exploration of proteome structure and function , 2016, Nature.

[20]  J. Wojcik,et al.  A NEUROINFLAMMATORY BIOMARKER SIGNATURE OF BLOOD-BRAIN BARRIER IMPAIRMENT IN OLDER ADULTS , 2016, Alzheimer's & Dementia.

[21]  E. Diamandis,et al.  Identification of brain-enriched proteins in the cerebrospinal fluid proteome by LC-MS/MS profiling and mining of the Human Protein Atlas , 2016, Clinical Proteomics.

[22]  Loïc Dayon,et al.  Proteomic Biomarker Discovery in 1000 Human Plasma Samples with Mass Spectrometry. , 2016, Journal of proteome research.

[23]  José A. Dianes,et al.  2016 update of the PRIDE database and its related tools , 2015, Nucleic Acids Res..

[24]  M. Kussmann,et al.  Proteomics of Cerebrospinal Fluid: Throughput and Robustness Using a Scalable Automated Analysis Pipeline for Biomarker Discovery. , 2015, Analytical chemistry.

[25]  Yajie Wang,et al.  A comprehensive map and functional annotation of the normal human cerebrospinal fluid proteome. , 2015, Journal of proteomics.

[26]  Ruedi Aebersold,et al.  Quantitative variability of 342 plasma proteins in a human twin population , 2015 .

[27]  G. von Heijne,et al.  Tissue-based map of the human proteome , 2015, Science.

[28]  J. Mulder,et al.  Affinity proteomic profiling of plasma, cerebrospinal fluid, and brain tissue within multiple sclerosis. , 2014, Journal of proteome research.

[29]  M. Kussmann,et al.  Comprehensive and Scalable Highly Automated MS-Based Proteomic Workflow for Clinical Biomarker Discovery in Human Plasma. , 2014, Journal of proteome research.

[30]  A. C. Kroksveen,et al.  Effects of Blood Contamination and the Rostro-Caudal Gradient on the Human Cerebrospinal Fluid Proteome , 2014, PloS one.

[31]  Sara Hall,et al.  Cerebrospinal fluid inflammatory markers in Parkinson’s disease – Associations with depression, fatigue, and cognitive impairment , 2013, Brain, Behavior, and Immunity.

[32]  G. Kokwaro,et al.  Plasma and Cerebrospinal Proteomes From Children With Cerebral Malaria Differ From Those of Children With Other Encephalopathies , 2013, The Journal of infectious diseases.

[33]  A. Baker,et al.  Application of Blood-Based Biomarkers in Human Mild Traumatic Brain Injury , 2013, Front. Neurol..

[34]  J. Trojanowski,et al.  Relationship between CSF and plasma proteomic data in the ADNI-1 cohort , 2012, Alzheimer's & Dementia.

[35]  R. Tibshirani,et al.  Regression shrinkage and selection via the lasso: a retrospective , 2011 .

[36]  J. Morris,et al.  The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[37]  Xavier Robin,et al.  pROC: an open-source package for R and S+ to analyze and compare ROC curves , 2011, BMC Bioinformatics.

[38]  Richard D. Smith,et al.  Establishing the Proteome of Normal Human Cerebrospinal Fluid , 2010, PloS one.

[39]  Trevor Hastie,et al.  Regularization Paths for Generalized Linear Models via Coordinate Descent. , 2010, Journal of statistical software.

[40]  J. Kaye,et al.  Blood–brain barrier impairment in Alzheimer disease , 2007, Neurology.

[41]  F. Jessen,et al.  [Diagnostic lumbar puncture performed in the outpatient setting of a memory clinic. Frequency and risk factors of post-lumbar puncture headache]. , 2007, Der Nervenarzt.

[42]  N. Gilhus,et al.  Guidelines on routine cerebrospinal fluid analysis. Report from an EFNS task force , 2006, European journal of neurology.

[43]  C. Jack,et al.  Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment , 2004, Journal of internal medicine.

[44]  M. Cavaglià,et al.  Peripheral markers of blood-brain barrier damage. , 2004, Clinica chimica acta; international journal of clinical chemistry.

[45]  D. Porte,et al.  Cerebrospinal fluid leptin levels: Relationship to plasma levels and to adiposity in humans , 1996, Nature Medicine.

[46]  E. DeLong,et al.  Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. , 1988, Biometrics.

[47]  R. Snaith,et al.  The Hospital Anxiety And Depression Scale , 2003, Health and quality of life outcomes.

[48]  G. Tibbling,et al.  Principles of albumin and IgG analyses in neurological disorders. III. Evaluation of IgG synthesis within the central nervous system in multiple sclerosis. , 1977, Scandinavian journal of clinical and laboratory investigation.

[49]  S. Folstein,et al.  “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician , 1975 .

[50]  Loïc Dayon,et al.  Relative Protein Quantification by MS/MS Using the Tandem Mass Tag Technology , 2012, Quantitative Methods in Proteomics.

[51]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.